4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 9, 2022.
4 other insiders sold within 30 days.
109 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Kreisler Amy Rollins sold about $561.7K of RES on Nov 11, 2022; 4 other insiders sold within 30 days and 109 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 9, 2022.
4 other insiders sold within 30 days.
109 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rollins Pam R sold about $561.7K of RES on Nov 11, 2022; 4 other insiders sold within 30 days and 109 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 9, 2022.
4 other insiders sold within 30 days.
109 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rollins Timothy Curtis sold about $561.7K of RES on Nov 11, 2022; 4 other insiders sold within 30 days and 109 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 8, 2022.
The trade is 2.2% of the 53,751 shares held after it.
4 other insiders sold within 30 days.
109 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rollins Pam R sold about $12.2K of RES on Nov 9, 2022; 4 other insiders sold within 30 days and 109 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 8, 2022.
The trade is 2.2% of the 53,751 shares held after it.
4 other insiders sold within 30 days.
109 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rollins Timothy Curtis sold about $12.2K of RES on Nov 9, 2022; 4 other insiders sold within 30 days and 109 funds added in the latest 13F quarter.
122 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM RES
FY Dec 2025
$1.6B
FY Dec 2024
$1.4B
FY Dec 2023
$1.6B
FY Dec 2022
$1.6B
FY Dec 2021
$864.9M
Jun 2026
$460.9M
Mar 2026
$454.8M
Dec 2025
$425.8M
Sep 2025
$447.1M
Jun 2025
$420.8M
Mar 2025
$332.9M
Dec 2024
$335.4M
Sep 2024
$337.7M
At each fiscal year end
Single quarter
Net margin, TTM
+1.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM RES
FY Dec 2025
+2.0%
FY Dec 2024
+6.5%
FY Dec 2023
+12.1%
FY Dec 2022
+13.6%
FY Dec 2021
+0.8%
Jun 2026
+2.6%
Mar 2026
+0.2%
Dec 2025
-0.7%
Sep 2025
+2.9%
Jun 2025
+2.4%
Mar 2025
+3.6%
Dec 2024
+3.8%
Sep 2024
+5.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
$39.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM RES
FY Dec 2025
$52.9M
FY Dec 2024
$129.5M
FY Dec 2023
$213.8M
FY Dec 2022
$61.7M
FY Dec 2021
-$19.9M
Jun 2026
$4.7M
Mar 2026
-$932.0K
Dec 2025
$31.2M
Sep 2025
$4.1M
Jun 2025
$10.0M
Mar 2025
$7.6M
Dec 2024
$53.7M
Sep 2024
$19.1M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity RES
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt RES
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity RES
FY Dec 2025
+2.9%
FY Dec 2024
+8.7%
FY Dec 2023
+20.8%
FY Dec 2022
+29.1%
FY Dec 2021
+1.1%
Jun 2026
+2.1%
Mar 2026
+1.9%
Dec 2025
+2.9%
Sep 2025
+4.4%
Jun 2025
+5.0%
Mar 2025
+7.2%
Dec 2024
+8.7%
Sep 2024
+11.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RES
FY Dec 2025
+2.2%
FY Dec 2024
+6.8%
FY Dec 2023
+16.2%
FY Dec 2022
+21.9%
FY Dec 2021
+0.9%
Jun 2026
+1.6%
Mar 2026
+1.5%
Dec 2025
+2.2%
Sep 2025
+3.4%
Jun 2025
+3.9%
Mar 2025
+5.8%
Dec 2024
+6.8%
Sep 2024
+9.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital RES
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+2.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed RES
FY Dec 2025
+3.6%
FY Dec 2024
+8.3%
FY Dec 2023
+23.5%
FY Dec 2022
+34.2%
FY Dec 2021
+2.3%
Jun 2026
+2.8%
Mar 2026
+2.9%
Dec 2025
+3.6%
Sep 2025
+4.9%
Jun 2025
+4.8%
Mar 2025
+6.6%
Dec 2024
+8.3%
Sep 2024
+11.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
62.50x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing RES
FY Dec 2025
34.00x
FY Dec 2024
13.81x
FY Dec 2023
8.09x
FY Dec 2022
8.80x
FY Dec 2021
227.00x
Jun 2026
58.30x
Mar 2026
70.80x
Dec 2025
34.00x
Sep 2025
20.70x
Jun 2025
18.19x
Mar 2025
15.28x
Dec 2024
13.81x
Sep 2024
11.36x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value RES
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.8%
TTM free cash flow over market value at close 2026-10-23
FCF yield RES
FY Dec 2025
+4.4%
FY Dec 2024
+10.1%
FY Dec 2023
+13.6%
FY Dec 2022
+3.2%
FY Dec 2021
-2.0%
Jun 2026
+3.0%
Mar 2026
+2.8%
Dec 2025
+4.4%
Sep 2025
+7.2%
Jun 2025
+8.7%
Mar 2025
+11.2%
Dec 2024
+10.1%
Sep 2024
+10.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -62%, PEG needs growth
PEG, trailing RES
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.00x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
RES ranks highest on growth (85th percentile) and risk and compliance (46th), and lowest on profitability (42nd), among Energy peers.
Profitability
42
Inputs
Return on equity+2.1% · 43 pct, sector of 109
Return on assets+1.6% · 45 pct, sector of 129
Return on invested capitalno debt line filed
Return on capital employed+2.8% · 39 pct, sector of 110
Growth
85
Inputs
Revenue growth, YoY+15.0% · 74 pct, sector of 141
Backlog growth, YoY+144.8% · 95 pct, universe of 854
Institutional and government
44
Inputs
Funds adding, latest quarter109 · 44 pct, sector of 145
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
46
Inputs
Short interest, % of float+17.2% · 11 pct, sector of 167
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 109
New text in Risk Factors, latest 10-K+14.3% · 29 pct, sector of 120
3 not measured: Financial health, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.